Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder. [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the safety, tolerability, and pharmacokinetics of multiple rising doses of TAK-137 in adults with attention-deficit/hyperactivity diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• TAK-137

Snippet

Sponsor: Takeda | Conditions: Attention-Deficit/Hyperactivity Disorder | Phase 1 | Status: TERMINATED | Results posted: 2016-07-11